Drug Shortage Report for OMNIPAQUE 180

Last updated on 2022-08-06 History
Report ID 163556
Drug Identification Number 02172720
Brand name OMNIPAQUE 180
Common or Proper name iohexol injection USP
Company Name GE HEALTHCARE CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) IOHEXOL
Strength(s) 388MG
Dosage form(s) SOLUTION
Route of administration SUBARACHNOIDAL SUBARACHNOIDAL
Packaging size 20 mL
ATC code V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-06-28
Estimated end date 2022-08-03
Actual end date 2022-08-05
Shortage status Resolved
Updated date 2022-08-06
Company comments Packaging material shortage
Health Canada comments Canadian Association of Radiologists: Statement on Iodinated Contrast Media Shortage - https://car.ca/news/statement-on-iodinated-contrast-media-shortage/
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@gehealthcare.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-08-06 English Compare
v7 2022-08-05 French Compare
v6 2022-08-05 English Compare
v5 2022-07-05 French Compare
v4 2022-07-05 English Compare
v3 2022-06-29 English Compare
v2 2022-06-28 French Compare
v1 2022-06-28 English Compare

Showing 1 to 8 of 8